These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8722543)

  • 21. Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial infections.
    Pai MP; Cojutti P; Pea F
    Clin Pharmacokinet; 2015 Sep; 54(9):933-41. PubMed ID: 25850987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of meropenem during continuous infusion in surgical ICU patients.
    Kees MG; Minichmayr IK; Moritz S; Beck S; Wicha SG; Kees F; Kloft C; Steinke T
    J Clin Pharmacol; 2016 Mar; 56(3):307-15. PubMed ID: 26222202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosing regimen of meropenem for adults with severe burns: a population pharmacokinetic study with Monte Carlo simulations.
    Ramon-Lopez A; Allen JM; Thomson AH; Dheansa BS; James SE; Hanlon GW; Stewart B; Davies JG
    J Antimicrob Chemother; 2015 Mar; 70(3):882-90. PubMed ID: 25362574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of plasma and interstitial fluid concentrations of doxycycline and meropenem following constant rate intravenous infusion in dogs.
    Bidgood TL; Papich MG
    Am J Vet Res; 2003 Aug; 64(8):1040-6. PubMed ID: 12926599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration.
    Jamal JA; Mat-Nor MB; Mohamad-Nor FS; Udy AA; Wallis SC; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2015 Jan; 45(1):41-5. PubMed ID: 25455853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of meropenem in febrile neutropenic patients. Swedish study group.
    Nyhlén A; Ljungberg B; Nilsson-Ehle I
    Eur J Clin Microbiol Infect Dis; 1997 Nov; 16(11):797-802. PubMed ID: 9447900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of meropenem and its metabolite in young and elderly healthy men.
    Ljungberg B; Nilsson-Ehle I
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1437-40. PubMed ID: 1510440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic and Pharmacodynamic Efficacies of Continuous versus Intermittent Administration of Meropenem in Patients with Severe Sepsis and Septic Shock: A Prospective Randomized Pilot Study.
    Zhao HY; Gu J; Lyu J; Liu D; Wang YT; Liu F; Zhu FX; An YZ
    Chin Med J (Engl); 2017 May; 130(10):1139-1145. PubMed ID: 28485312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Capillary zone electrophoresis determination of meropenem in biological media using a high sensitivity cell.
    Mrestani Y; Neubert R; Nagel F
    J Pharm Biomed Anal; 1999 Sep; 20(6):899-903. PubMed ID: 10746958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meropenem pharmacokinetics and penetration into an inflammatory exudate.
    Wise R; Logan M; Cooper M; Ashby JP; Andrews JM
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1515-7. PubMed ID: 2221860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.
    Shekar K; Fraser JF; Taccone FS; Welch S; Wallis SC; Mullany DV; Lipman J; Roberts JA;
    Crit Care; 2014 Dec; 18(6):565. PubMed ID: 25636084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intramuscular meropenem in the treatment of bacterial infections of the urinary and lower respiratory tracts. Italian Intramuscular Meropenem Study Group.
    Romanelli G; Cravarezza P
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():109-19. PubMed ID: 8543487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.
    Roberts JA; Kirkpatrick CM; Roberts MS; Robertson TA; Dalley AJ; Lipman J
    J Antimicrob Chemother; 2009 Jul; 64(1):142-50. PubMed ID: 19398460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Open, Randomized, Single-Center, Crossover Pharmacokinetic Study of Meropenem after Intraperitoneal and Intravenous Administration in Patients Receiving Automated Peritoneal Dialysis.
    Wiesholzer M; Pichler P; Reznicek G; Wimmer M; Kussmann M; Balcke P; Burgmann H; Zeitlinger M; Poeppl W
    Antimicrob Agents Chemother; 2016 May; 60(5):2790-7. PubMed ID: 26902765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of meropenem in patients with various degrees of renal function, including patients with end-stage renal disease.
    Chimata M; Nagase M; Suzuki Y; Shimomura M; Kakuta S
    Antimicrob Agents Chemother; 1993 Feb; 37(2):229-33. PubMed ID: 8452352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and pharmacodynamics of meropenem in children with severe infection.
    Kongthavonsakul K; Lucksiri A; Eakanunkul S; Roongjang S; Issaranggoon Na Ayuthaya S; Oberdorfer P
    Int J Antimicrob Agents; 2016 Aug; 48(2):151-7. PubMed ID: 27345269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The disposition and metabolic fate of 14C-meropenem in man.
    Harrison MP; Haworth SJ; Moss SR; Wilkinson DM; Featherstone A
    Xenobiotica; 1993 Nov; 23(11):1311-23. PubMed ID: 8310714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of meropenem in preterm neonates.
    van Enk JG; Touw DJ; Lafeber HN
    Ther Drug Monit; 2001 Jun; 23(3):198-201. PubMed ID: 11360025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients.
    Robatel C; Decosterd LA; Biollaz J; Eckert P; Schaller MD; Buclin T
    J Clin Pharmacol; 2003 Dec; 43(12):1329-40. PubMed ID: 14615469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.